Cargando…

Updates on Novel Non-Replacement Drugs for Hemophilia

Over the last decade, the world of hemophilia has experienced an unprecedented therapeutic advance, thanks to the progress in bioengineering technologies, leading to the introduction of drugs with novel mechanisms of action based on restoring thrombin generation or coagulation factor VIII mimicking....

Descripción completa

Detalles Bibliográficos
Autores principales:	Gualtierotti, Roberta, Pasca, Samantha, Ciavarella, Alessandro, Arcudi, Sara, Giachi, Andrea, Garagiola, Isabella, Suffritti, Chiara, Siboni, Simona Maria, Peyvandi, Flora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611302/ https://www.ncbi.nlm.nih.gov/pubmed/36297295 http://dx.doi.org/10.3390/ph15101183

Ejemplares similares

Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study
por: Suffritti, Chiara, et al.
Publicado: (2023)

Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy
por: La Mura, Vincenzo, et al.
Publicado: (2023)

Anti-emicizumab antibodies do not cross-react with mim8 in vitro
por: Valsecchi, Carla, et al.
Publicado: (2023)

Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)

Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)

Product type and other environmental risk factors for inhibitor development in severe hemophilia A
por: Peyvandi, Flora, et al.
Publicado: (2018)

Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19
por: Boggio, Federico, et al.
Publicado: (2022)

Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit
por: Gualtierotti, Roberta, et al.
Publicado: (2022)

Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia
por: Boccalandro, Elena Anna, et al.
Publicado: (2023)

Current and Emerging Approaches for Pain Management in Hemophilic Arthropathy
por: Gualtierotti, Roberta, et al.
Publicado: (2022)

Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
por: Giachi, Andrea, et al.
Publicado: (2022)

Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia A
por: Spena, Silvia, et al.
Publicado: (2022)

Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity
por: Donadon, Irving, et al.
Publicado: (2018)

Development of a Specific Monoclonal Antibody to Detect Male Cells Expressing the RPS4Y1 Protein
por: Spena, Silvia, et al.
Publicado: (2021)

A recurrent F8 mutation (c.6046C>T) causing hemophilia A in 8% of northern Italian patients: evidence for a founder effect
por: Garagiola, Isabella, et al.
Publicado: (2015)

Immune Responses to Plasma-Derived Versus Recombinant FVIII Products
por: Peyvandi, Flora, et al.
Publicado: (2021)

Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients
por: Gualtierotti, Roberta, et al.
Publicado: (2023)

Hemophilic arthropathy: Current knowledge and future perspectives
por: Gualtierotti, Roberta, et al.
Publicado: (2021)

Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
por: Ciavarella, Alessandro, et al.
Publicado: (2020)

The Arrival of Gene Therapy for Patients with Hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2022)

The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients
por: Pagliari, Maria Teresa, et al.
Publicado: (2022)

Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding
por: Cugno, Massimo, et al.
Publicado: (2014)

Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review
por: Pasca, Samantha, et al.
Publicado: (2022)

Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient’s Perspectives
por: Pasca, Samantha
Publicado: (2022)

Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
por: Capecchi, Marco, et al.
Publicado: (2023)

Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs
por: Castaman, Giancarlo, et al.
Publicado: (2023)

Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review
por: Shapiro, Amy D., et al.
Publicado: (2022)

The evolution of physiotherapy in the multidisciplinary management of persons with haemophilia (PWH): A scoping review
por: Boccalandro, Elena A., et al.
Publicado: (2022)

Total Ankle Replacement in Hemophilia
por: Rodriguez-Merchan, Emerito C.
Publicado: (2020)

Genetic Variants Identified by Whole Exome Sequencing in a Large Italian Family with High Plasma Levels of Factor VIII and Von Willebrand Factor
por: Spena, Silvia, et al.
Publicado: (2023)

Handwriting Analysis in Children and Adolescents with Hemophilia: A Pilot Study
por: Pasta, Gianluigi, et al.
Publicado: (2020)

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH
por: van Galen, Karin P. M., et al.
Publicado: (2021)

No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2
por: Peyvandi, Flora, et al.
Publicado: (2021)

Hemophilia gene therapy knowledge and perceptions: Results of an international survey
por: Peyvandi, Flora, et al.
Publicado: (2020)

Successful Chemical Synovectomy in a Patient with Acquired von Willebrand Syndrome with Chronic Synovitis Due to Recurrent Knee Hemarthrosis: A Case Report
por: Gualtierotti, Roberta, et al.
Publicado: (2022)

Application of a hemophilia mortality framework to the Emicizumab Global Safety Database
por: Peyvandi, Flora, et al.
Publicado: (2020)

Complement activation in patients with COVID-19: A novel therapeutic target
por: Cugno, Massimo, et al.
Publicado: (2020)

Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem
por: Cugno, Massimo, et al.
Publicado: (2021)

Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies
por: Peyvandi, Flora, et al.
Publicado: (2020)

Pulmonary embolism in a young pregnant woman with COVID-19
por: Martinelli, Ida, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vcvh18uh7q2q68l63iqvp98su6